Stay updated with breaking news from Michaell Wang. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
INDIANAPOLIS, Nov. 3, 2022 /PRNewswire/ -- Loxo@Lilly, the oncology unit of Eli Lilly and Company (NYSE: LLY), today announced that study investig...
Patients with untreated mantle-cell lymphoma aged 65 years or older were randomly assigned to receive ibrutinib or placebo.
/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced primary results from the Phase 3 SHINE study (Abstract #7502), which...
/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced primary results from the Phase 3 SHINE study (Abstract #7502), which...
Response rate of 98% with ibrutinib-rituximab in mantle cell lymphoma patients 65 and under